Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,794
Closed -$249 205
2017
Q4
$249 Sell
5,794
-13,900
-71% -$641K 0.05% 171
2017
Q3
$981K Sell
19,694
-600
-3% -$29K 0.22% 85
2017
Q2
$972K Sell
20,294
-2,150
-10% -$103K 0.23% 85
2017
Q1
$1.02M Buy
22,444
+11,850
+112% +$503K 0.24% 84
2016
Q4
$428K Sell
10,594
-1,375
-11% -$54.2K 0.11% 128
2016
Q3
$457K Buy
11,969
+1,800
+18% +$72.2K 0.11% 133
2016
Q2
$426K Buy
10,169
+1,360
+15% +$55.8K 0.1% 129
2016
Q1
$354K Sell
8,809
-12,500
-59% -$502K 0.08% 123
2015
Q4
$909K Sell
21,309
-1,808
-8% -$83.2K 0.21% 75
2015
Q3
$1.1M Sell
23,117
-825
-3% -$42K 0.26% 68
2015
Q2
$1.19M Sell
23,942
-2,832
-11% -$144K 0.23% 75
2015
Q1
$1.32M Sell
26,774
-1,408
-5% -$67.3K 0.24% 73
2014
Q4
$1.28M Sell
28,182
-5,142
-15% -$249K 0.27% 65
2014
Q3
$1.88M Buy
33,324
+675
+2% +$36.3K 0.44% 49
2014
Q2
$1.74M Buy
32,649
+6,375
+24% +$338K 0.43% 47
2014
Q1
$1.37M Buy
26,274
+3,960
+18% +$200K 0.38% 47
2013
Q4
$1.2M Buy
+22,314
New +$1.15M 0.37% 50

Other funds holding SNY

Bank Hapoalim BM's SNY Position: Q1 2018 in Review

Bank Hapoalim BM sold out of Sanofi (SNY) in Q1 2018, closing a stake of 5,794 shares — an estimated $249 sold.

Bank Hapoalim BM first reported a position in SNY in Q4 2013 and held it in 17 quarters. The position peaked at $1.88M in Q3 2014. 486 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • Bank Hapoalim BM reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
  • Bank Hapoalim BM sold 5,794 Sanofi shares in Q1 2018, an estimated $249.
  • Bank Hapoalim BM first reported a position in Sanofi in Q4 2013 and held it in 17 quarters.
  • Bank Hapoalim BM's Sanofi position peaked at $1.88M in Q3 2014.
  • 486 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Bank Hapoalim BM's 13F filing for Q1 2018, filed 30 Apr 2018.